About The Max Foundation

Our vision is a world where all people facing cancer live with dignity and hope.

See why we believe in this vision.

Our mission is to increase global access to treatment, care, and support for people living with cancer.

See how we are making our mission a reality.

Our Story

In 1997, The Max Foundation was established in honor of Maximiliano (Max) Rivarola and his legacy inspires our vision for a world where all people facing cancer live with dignity and hope. Max’s family brought him from Argentina to the United States for treatment, where he lived courageously with a kind of blood cancer known as chronic myeloid leukemia (CML) for three years. With his passing, Max’s family was determined to help other families in Latin America with children diagnosed with leukemia, and that was our original mission.

What began as a grassroots organization with several volunteers has evolved into a specialized team of more than 50 professionals. We carry out our work with team members based in Seattle at our headquarters and in many targeted low and middle income countries. Through the years, we have expanded our mission. The Max Foundation now has a full range of programs and services, all focused on serving people living with cancer around the world.

The Max Foundation is a 501(c)3 non-profit organization. Our international non-profit functions as an operating foundation with all funds raised spent directly on our programs and not as grants to other charitable organizations. We rely on your public donations to fund our global efforts. Partner with us in our mission, please give today.

Everything we do aims at creating a world where all people facing cancer live with dignity and hope. We are treating people, not just the disease. We partner with families in their cancer journey, we foster leadership among cancer survivors, and we collaborate with local patient associations to create positive social change in communities.”

—Pat Garcia-Gonzalez, CEO of The Max Foundation

Our Executives

Leadership Team

Our Leadership Team, which is mission focused and responsible for strategy, finances and management, includes executives from our headquarters and region heads based in the US and in regional offices around the world.

Pat Garcia-Gonzalez

Chief Executive Officer; Global Headquarters in Seattle, USA

Erin Schwartz

Vice President of Strategic Partnerships and Communications; Global Headquarters in Seattle, USA

Danielle M. Matia

Region Head for Africa & Middle East; Global Headquarters in Seattle, USA

Inés García González

Region Head for Latin America; Latin America Regional Office in Buenos Aires, Argentina

Mei Ching Ong

Region Head for Asia Pacific; Asia Pacific Regional Office in Kuala Lumpur, Malaysia

Viji Venkatesh

Region Head for South Asia; Regional Office in Mumbai, India

J. Michael Wrigglesworth

Director of Global Information Technology Solutions; Global Headquarters in Seattle, USA

Ann Kim Novakowski

Senior Program Manager; Global Headquarters in Seattle, USA

Executive Board

Our Board of Directors is comprised of professionals dedicated to serving our mission. The Board provides governance and fiduciary oversight, along with guiding policy and assessing organizational performance goals. We are extremely grateful for their ongoing support.

Paula Boultbee

President of the Board

Principal at PTB Consulting LLC

Jerry Scott, CPA

Treasurer of the Board

Chartered Global Management Accountant

David Tingstad

Secretary of the Board

Beresford Booth PLLC Law

Pat Garcia-Gonzalez

CEO of The Max Foundation

Robert Farmer

Board Member

CML survivor and photographer

Tracey Higgins

Board Member

Edmonds Community College

Grant Rubenstein

Board Member

Rosen~Harbottle Commercial Real Estate

Medical Advisory Board

Our Medical Advisory Board includes specialists who are key opinion leaders in the field of oncology. Based all around the world, these expert physicians are formative in leading research and managing patient care at their centers of excellence. We are extremely honored to benefit from their expertise and dedication to the patients we serve.

Hematology Advisors

Michele Baccarani, MD

Head of the Institute of Hematology and Medical Oncology “L. and A. Seràgnoli”, S. Orsola at the University Hospital, Bologna, Italy.

Jorge E. Cortes, MD

Professor of Medicine, Chief/CML Section, Deputy Chair, Department of Leukemia, MD Anderson Cancer Center in Houston, Texas, USA.

Brian J. Druker, MD

Investigator, Howard Hughes Medical Institute, JELD-WEN Chair of Leukemia Research, USA.

Francois Guilhot, MD

Head of the Department of Oncology, Hematology and Cell Therapy at The University Hospital of Poitier. President of the Chronic Myelogenous Leukemia French Group, France.

Andreas Hochhaus, MD

Klinikum Mannheim der University Heidelberg in Mannheim, Germany.

Timothy Hughes, MD

Hanson Institute, SA Pathology Adelaide, South Australia.

Michael J. Mauro, MD

Leader, Myeloproliferative Diseases Program Member, Memorial Sloan Kettering Cancer Center Professor of Medicine, Cornell University Medical College, New York, USA.

Javier Pinilla-Ibarz, MD, PhD

Associate Member and Director of Immunotherapy. Malignant Hematology Division. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Jerald Radich, MD

Clinical Research Division, Member with Fred Hutchinson Cancer Research Center and Professor of Medicine at University of Washington, USA.

Neil P. Shah, MD, PhD

Edward S. Ageno Distinguished Professor in Hematology/Oncology Leader, Hematopoietic Malignancies Program Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, USA.

Moshe Talpaz, MD

Assoc. Director for Translational Research, The University of Michigan Health Systems, Ann Arbor, Michigan, USA.


Oncology Advisors

Matías Chacón, MD

Medical Oncologist at the Instituto Médico Alexander Fleming in Buenos Aires, Argentina.

George D. Demetri, MD

Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School, USA.

Peter Reichardt, MD

Head of the Department of Interdisciplinary Oncology Director of the Sarcoma Center Berlin-Brandenburg Director of the Cancer Center Berlin-Buch at HELIOS Klinikum Berlin-Buch in Berlin, Germany.

Jonathan Trent, MD

Co-Director, Musculosketal Center Director, Sarcoma Medical Research Program Professor of Medicine at Sylvester Cancer Center in Miami, Florida, USA.



Strategic Innovation Advisory Board

Hailing from both the public and private sectors, our Strategic Innovation Advisory Board includes incredible leaders in the fields of global health, fundraising, business and communications who lend their advice, skills and expertise towards achieving our mission. We thank our strategic advisors for their mentorship and guidance in our daily work.

Carolyn Blasdel, FNP-BC

Tacoma, USA.

R. Banks Bourne, MBA

Chief Executive Officer, Bourne Partners, Charlotte, North Carolina, USA

Rhonda Curry

Interim VP, Communications at Fred Hutchinson Cancer Research Center, Seattle, USA

Gilberto de Lima Lopes, Jr., MD, MBA, FAMS

Associate Professor of Clinical Medicine, Medical Director for International Programs and Associate Director of Global Oncology at Sylvester Comprehensive Cancer Center at the University of Miami, Miami, USA.

Michele Galen, J.D.

Communications Consulting and Transition Coach, Boston, USA.

Teresa Guillien, MPA

Managing Program Director Resource Media and Faculty in the Nonprofit Management Certificate Program at the University of Washington, USA.

William E. Heisel, Journalism BA

Director of Global Engagement, The Institute of Health Metrics and Evaluation (IHME) at the University of Washington, USA.

Michael Mandola, PhD

President (US Operations), Nucleus Global

 Jerald Radich, MD

Clinical Research Division, Member with Fred Hutchinson Cancer Research Center and Professor of Medicine at University of Washington, USA.

Carlos Rodriguez-Galindo, MD

Executive Vice-President, Director of International Outreach Program, Chair, Department of Global Pediatric Medicine Four Stars of Chicago Chair of International Pediatric Research St. Jude Children’s Research Hospital; Memphis, TN, USA.

Lawrence N. Shulman, MD

Deputy Director for Clinical Services, Director Center for Global Cancer Medicine, Abramson Cancer Center at University of Pennsylvania, USA.

Kristofer Rogers

Director of Marketing & Fundraising at Cancer Council Australia, Sydney, Australia.

Dr. Andy Stergachis, PhD, BPharm

Professor of Pharmacy and Global Health, Associate Dean of School of Pharmacy, and Director of the Global Medicines Program, University of Washington (UW).

Our Global Presence

The Max Foundation has over 50 team members in the US and in targeted countries, all dedicated to improving global access to treatment, care and support for people affected by cancer around the world.

Our international team is comprised of trained global advocates. They are professionals from the country where they are based who possess a variety of backgrounds from the non-profit sector, social work, psychology, and other health-related fields. Team members speak the local languages and have an authentic understanding of the cultural customs and norms within their home country, including an awareness of health systems.

Africa & Middle East Office

Johannesburg, South Africa

Asia Pacific Office

Kuala Lumpur, Malaysia

Latin America Office

Buenos Aires, Argentina

South Asia Office

Mumbai, India

The Max Foundation also has team members in: Santiago, Chile; Santa Domingo, Dominican Republic; Guatemala City, Guatemala; Mexico City and Monterrey, Mexico; Manila, Philippines; Senegal; Johannesburg, South Africa; Bangkok, Thailand; and Tashkent, Uzbekistan.

Global Partnerships & Affiliations

Our global partnerships within alliances and as part of member based organizations extend our reach and impact throughout the world. Collaboration with these like-minded associations include ongoing joint projects, as well as shared initiatives and resources.